Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Validation of new renal staging system in AL amyloidosis treated with high dose melphalan and stem cell transplantation

Published:2016-07-14 Issue:10 Volume:91 Page:E458-E460
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:Am. J. Hematol.

Author:

Havasi Andrea¹²,Stern Lauren¹²,Lo Stephen²,Sun Fangui³,Sanchorawala Vaishali²⁴

Affiliation:

1. Department of Nephrology; Boston University School of Medicine; Boston Massachusetts

2. Amyloidosis Center; Boston University School of Medicine; Boston Massachusetts

3. Department of Biostatistics; Boston University School of Public Health; Boston Massachusetts

4. Section of Hematology-Oncology; Boston University School of Medicine; Boston Massachusetts

Funder

Amyloid Research Fund at Boston University School of Medicine

National Institutes of Health

Publisher

Wiley

Subject

Hematology

Reference6 articles.

1. A staging system for renal outcome and early markers of renal response to chemotherapy in AL amyloidosis;Palladini;Blood,2014

2. Outcome of AL amyloidosis after high-dose melphalan and autologous stem cell transplantation: Long-term results in a series of 421 patients;Cibeira;Blood,2011

3. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004;Gertz;Am J Hematol,2005

4. Incidence and outcome of acute renal failure complicating autologous stem cell transplantation for AL amyloidosis;Fadia;Kidney Int,2003

5. Renal risk and response in amyloidosis;Dispenzieri;Blood,2014

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine‐learning based subgroups of AL amyloidosis and cumulative incidence of mortality and end stage kidney disease;American Journal of Hematology;2024-09-11

2. Long‐term outcomes of renal AL amyloidosis patients undergoing autologous stem cell transplantation: Validating the performance of the renal staging system;American Journal of Hematology;2024-08-29

3. Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis;Bone Marrow Transplantation;2024-04-24

4. Renal AL Amyloidosis: Updates on Diagnosis, Staging, and Management;Journal of Clinical Medicine;2024-03-18

5. Systemic Amyloidosis and Kidney Transplantation: An Update;Seminars in Nephrology;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3